Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by nobody – 2019-04-05 08:37 (1025 d 04:38 ago) – Posting: # 20124
Views: 2,947

» The fact that it is also a royal waste of money is of course only secondary.

Full-blown development mode. Accept it. Tell the sponsor you can't do the trial, if you are not qualified for PD-endpoint testing.

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
21,848 posts in 4,572 threads, 1,555 registered users;
online 7 (1 registered, 6 guests [including 3 identified bots]).
Forum time: Monday 12:15 CET (Europe/Vienna)

Do, or do not.
There is no ‘try’.    Yoda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5